Bharat Biotech to launch Covaxin in Q2 2021

Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said. The company's vaccine candidate- Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes Covid-19.